Achillion Pharmaceuticals Inc - Strategic SWOT Analysis Review

January 2021 | 23 pages | ID: AAB38DE94F4AEN
GlobalData

Abstracts

Achillion Pharmaceuticals Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – GlobalData’s summarization of the company’s business strategy.
• SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

Achillion Pharmaceuticals Inc (Achillion), a subsidiary of Alexion Pharmaceuticals Inc, is a biopharmaceutical company that focuses on the discovery and development of small molecule therapeutic products for treatment of infectious diseases and immune system related disorders. The company focuses on developing life-saving medicines for patients with rare diseases. It is developing oral antiviral therapy for chronic hepatitis C (HCV) and a platform of potent and specific complement inhibitors. Achillion intends to develop and commercialize factor D inhibitors for rare diseases including paroxysmal nocturnal hemoglobinuria (PNH), C3 Glomerulopathy (C3G), dry age-related macular degeneration (dry AMD). Achillion is headquartered in New Haven, Connecticut, the US.

Reasons to Buy

• Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
• Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
• Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
• Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Contents

Table of Contents
List of Tables
List of Figures

SECTION 1 - ABOUT THE COMPANY

Achillion Pharmaceuticals Inc - Key Facts
Achillion Pharmaceuticals Inc - Key Employees
Achillion Pharmaceuticals Inc - Key Employee Biographies
Achillion Pharmaceuticals Inc - Major Products and Services
Achillion Pharmaceuticals Inc - History
Achillion Pharmaceuticals Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Achillion Pharmaceuticals Inc - Business Description
Achillion Pharmaceuticals Inc - Corporate Strategy
Achillion Pharmaceuticals Inc - SWOT Analysis
SWOT Analysis - Overview
Achillion Pharmaceuticals Inc - Strengths
Achillion Pharmaceuticals Inc - Weaknesses
Achillion Pharmaceuticals Inc - Opportunities
Achillion Pharmaceuticals Inc - Threats
Achillion Pharmaceuticals Inc - Key Competitors

SECTION 3 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Achillion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Achillion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Achillion Pharmaceuticals Inc, Recent Deals Summary

SECTION 4 – APPENDIX

Methodology
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Achillion Pharmaceuticals Inc, Key Facts
Achillion Pharmaceuticals Inc, Key Employees
Achillion Pharmaceuticals Inc, Key Employee Biographies
Achillion Pharmaceuticals Inc, Major Products and Services
Achillion Pharmaceuticals Inc, History
Achillion Pharmaceuticals Inc, Other Locations
Achillion Pharmaceuticals Inc, Key Competitors
Achillion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Achillion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Achillion Pharmaceuticals Inc, Recent Deals Summary

List Of Figures

LIST OF FIGURES

Achillion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Achillion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021

COMPANIES MENTIONED

Regeneron Pharmaceuticals Inc
Ra Pharmaceuticals, Inc.
Omeros Corporation
Novartis AG
ChemoCentryx, Inc
Amyndas Pharmaceuticals LLC
Amgen Inc
Akari Therapeutics Plc